EGI
TWST icon

EAM Global Investors’s Twist Bioscience TWST Stock Holding History

EAM Global Investors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-83,300
Closed -$4.11M – 128
2024
Q2 		$4.11M Buy
+83,300
New +$3.4M 0.92% 75

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM Global Investors's TWST Position: Q3 2024 in Review

EAM Global Investors sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 83,300 shares — an estimated $4.11M sold.

EAM Global Investors first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $4.11M in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • EAM Global Investors reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • EAM Global Investors sold 83,300 Twist Bioscience shares in Q3 2024, an estimated $4.11M.
  • EAM Global Investors first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
  • EAM Global Investors's Twist Bioscience position peaked at $4.11M in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on EAM Global Investors's 13F filing for Q3 2024, filed 13 Nov 2024.